NOVOSIS DENT: Advanced Bone Growth Solution with rhBMP-2 and HA Carrier NOVOSIS DENT is a cutting-edge bone growth solution specifically designed for dental applications. It combines the power of recombinant human bone morphogenetic protein-2 (rhBMP-2) with a highly compatible hydroxyapatite (HA) carrier. With a focus on safety, efficacy, and versatility, NOVOSIS DENT offers an ideal solution for bone regeneration in dental procedures. Key Features and Benefits: Ideal Solution for Bone Growth: NOVOSIS DENT provides an optimal environment for bone growth, promoting osteogenesis, osteoconduction, and osteointegration. It accelerates bone regeneration and supports the successful integration of dental implants. Safety of Highly Purified BMP-2: The rhBMP-2 used in NOVOSIS DENT is highly purified, ensuring its safety and minimizing the risk of adverse effects. It has undergone rigorous testing and meets stringent quality standards. Excellent Efficacy for Sinus Augmentation: NOVOSIS DENT demonstrates remarkable efficacy in sinus augmentation procedures. It stimulates bone growth in the maxillary sinus area, allowing for successful implant placement and enhanced functional and aesthetic outcomes. Superior Compatibility with Various Implants: The HA carrier used in NOVOSIS DENT exhibits superior compatibility with a wide range of dental implants. It provides a stable scaffold for bone regeneration and facilitates the integration of the implant with the surrounding bone tissue. Indications: NOVOSIS DENT is indicated for the following dental procedures: Sinus Lift Guided Bone Regeneration (GBR) Bone Reconstruction (BronJ) Specification: BPGM0025: NOVOSIS DENT, HAGM, BMP-2 0.25mg BPGM0050: NOVOSIS DENT, HAGM, BMP-2 0.50mg BPGM0100: NOVOSIS DENT, HAGM, BMP-2 1.00mg BPGL0050: NOVOSIS DENT, HAGL, BMP-2 0.50mg BPGL0100: NOVOSIS DENT, HAGL, BMP-2 1.00mg BPGL0101: NOVOSIS DENT, HAGL, BMP-2 1.00mg BPGM0300: NOVOSIS DENT, HAGM, BMP-2 3.00mg BPGL0300: NOVOSIS DENT, HAGL, BMP-2 3.00mg Research Information: Effects of porous beta-tricalcium phosphate-based ceramics used as an E.coli-derived rhBMP-2 carrier for bone regeneration. Comparative study of fusion rate induced by different dosages of Escherichia coli–derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Effects of porous beta-tricalcium phosphate-based ceramics used as an E.coli-derived rhBMP-2 carrier for bone regeneration. NOVOSIS DENT offers dental professionals a reliable and innovative solution for bone regeneration in various clinical scenarios. It promotes efficient bone growth, supports successful implant placement, and ultimately contributes to improved patient outcomes. Consultation with dental experts and adherence to established clinical protocols are recommended for the proper use of NOVOSIS DENT in specific dental procedures.
